ALS: Newly discovered subtypes and sex differences create new approaches for drugs
A study by TUM researchers discovered four subtypes of Amyotrophic Lateral Sclerosis (ALS) with different molecular processes, including sex differences. The findings suggest repurposing an approved cancer drug targeting the MAPK pathway as a promising therapeutic approach for ALS.
SourceTechnical University of Munich (TUM)·JournalNature Communications·TypeData/statistical analysis·DateJun 21, 2024